PUBLIC COMPANY
save$CLYMClimb Bio, Inc.
$CLYMWellesley Hills, MA, USupdated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
- phase2A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
- phase1A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
- phase2A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
- EP1A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers
- phase1A Phase 1 Study of CLYM116 in Normal Healthy Volunteers
Insider activity
source: SEC Form 4🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that